2012World Clinical DrugsRequires access

Clinical observation of edaravone combined with argatroban in the treatment of progressive cerebral infarction

Tao Yang

Open publisher page 0 citations

Abstract

Objective To observe the clinical effects of edaravone combined with argatroban for the progressive cerebral infarction(PCI).Methods Seventy PCI patients were recruited and randomly divided into treatment group(administered with edaravone and argatroban,n=36) and control group(administered with argatroban only,n=34).Curative effect was evaluated by neurological function deficit scale and clinical manifestation.The blood and urinary routine test,liver function,renal function and electrocardiogram were also carried out before and after the treatment to detect the adverse drug reactions(ADRs).Results The grade of neurological function deficit scale in treatment group were improved significantly after treatment(P0.01).There was difference between treatment group and control group for overall response rate(P0.05) and there were no ADRs in both groups.Conclusion Edaravone combined with argatroban is an effective and safe therapeutic regimen for PCI patients.

About this research paper

What this paper is about

Objective To observe the clinical effects of edaravone combined with argatroban for the progressive cerebral infarction(PCI).Methods Seventy PCI patients were recruited and randomly divided into treatment group(administered with edaravone and argatroban,n=36) and control group(administered with argatroban only,n=34).Curative effect was evaluated by neurological function deficit scale and clinical manifestation.The blood and urinary routine test,liver function,renal function and electrocardiogram were also carried out before and after the treatment to detect the adverse drug reactions(ADRs).Results The grade of neurological function deficit scale in treatment group were improved significantly after treatment(P0.01).There was difference between treatment group and control group for overall response rate(P0.05) and there were no ADRs in both groups.Conclusion Edaravone combined with argatroban is an effective and safe therapeutic regimen for PCI patients.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the clinical effects of edaravone combined with argatroban for the progressive cerebral infarction(PCI).Methods Seventy PCI patients were recruited and randomly divided into treatment group(administered with edaravone and argatroban,n=36) and control group(administered with argatroban only,n=34).Curative effect was evaluated by neurological function deficit scale and clinical manifestation.The blood and urinary routine test,liver function,renal function and electrocardiogram were also carried out before and after the treatment to detect the adverse drug reactions(ADRs).Results The grade of neurological function deficit scale in treatment group were improved significantly after treatment(P0.01).There was difference between treatment group and control group for overall response rate(P0.05) and there were no ADRs in both groups.Conclusion Edaravone combined with argatroban is an effective and safe therapeutic regimen for PCI patients.

Key concepts: Medicine, Argatroban, Edaravone, Conventional PCI, Cerebral infarction, Neurological deficit, Regimen, Clinical efficacy

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical observation of edaravone combined with argatroban in the treatment of progressive cerebral infarction — Research Paper | ScholarLens